ClinicalTrials.gov
public full text
Public Domain
Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
This is a Phase II within-subjects double-blind placebo-controlled human laboratory study. The purpose of the study is to determine the efficacy of varenicline (Chantix) for reducing cue-induced cocaine and alcohol craving.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement#1030771
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt#1030434
- Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients#837350
- Varenicline and Motivational Advice for Smokers With Substance Use Disorders#1171959
- Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment#867529
Record · ID 908840
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive